Tag Archives: Martin Shkreli

Boston.com reports: Pharmaceutics CEO Martin Shkreli wanted to make a donation to Bernie Sanders’ campaign in order to get a meeting with the Vermont senator, according to Stat. The Sanders campaign said no thanks. They’ll be passing on the money to a Washington health clinic, and Shkreli—the so-called “most hated” man in America whose company, Turing Pharmaceuticals, raised the price …

Today the Human Rights Campaign sent a letter to New York Attorney General Eric Schneiderman [photo] in which they call for an investigation of price-gouging by pharma CEO Martin Shkreli.  HRC head Chad Griffin writes: Daraprim is a lifesaving treatment for toxoplasmosis, a parasitic infection impacting patients with compromised immune systems including those who are pregnant or living with HIV. …

But he won’t say by how much. NBC News reports: The pharmaceutical company boss under fire for increasing the price of the drug Daraprim by more than 5,000 percent said Tuesday he will lower the cost of the life-saving medication. Martin Shkreli did not say what the new price would be, but expected a determination to be made over the …

Hillary Clinton yesterday tweeted the above reaction to a New York Times story about drug price gouging. Then this happened: The former first lady’s comments clearly spooked investors. The iShares Nasdaq Biotechnology ETF (IBB) went from flat on the day before the Clinton tweet to closing down nearly 5%. Biotech stocks helped knock the Nasdaq into the red on what …

Yesterday we learned that pharma CEO Martin Shkreli has raised the price of a vital AIDS drug by 5500%. Folks have gone digging into Shkreli’s past and there’s quite a story there. US Uncut reports that Shkreli was recently accused of hacking the email account of a rival pharma executive and threatening his family. They write: The report, taken by …

Raw Story reports: Appearing on Bloomberg TV, the CEO of a pharmaceutical company that recently hiked the price of a drug used for critically ill infants and AIDS patients by 5,500 percent, defended the price increase by promising better things to come for future patients. Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, recently purchased the rights …